Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts
Primary Purpose
Thoracoabdominal Aneurysm, Abdominal Aortic Aneurysm
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Endovascular Aneurysm Repair
Sponsored by
About this trial
This is an interventional treatment trial for Thoracoabdominal Aneurysm
Eligibility Criteria
Inclusion Criteria:
- At least 18 years of age.
- Not pregnant
- Willing and able to comply with two-year follow-up period.
- Willing and able to give informed consent prior to enrollment
- No known allergy to stainless steel or polyester
- No history of anaphylactic reaction to contrast material with an inability to properly prophylax the patient appropriately.
- Life expectancy greater than two years
- High risk candidate for open surgical repair
Exclusion Criteria:
see above
Sites / Locations
- Cleveland Clinic
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Endovascular Aneurysm Repair
Arm Description
Endovascular Aneurysm Repair of TAAA/AAA with Fenestrated/Branched Stent Grafts
Outcomes
Primary Outcome Measures
Freedom From Aneurysm Rupture
Absence of blood extravasation outside of aneurysm sac demonstrated by CT scan
Secondary Outcome Measures
Full Information
NCT ID
NCT00583050
First Posted
December 20, 2007
Last Updated
April 29, 2020
Sponsor
The Cleveland Clinic
Collaborators
Massachusetts General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00583050
Brief Title
Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts
Official Title
Endovascular Exclusion of Thoracoabdominal Aortic Aneurysms or Abdominal Aneurysms Utilizing Fenestrated/Branched Stent-Grafts
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
February 2001 (Actual)
Primary Completion Date
December 31, 2019 (Actual)
Study Completion Date
February 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Cleveland Clinic
Collaborators
Massachusetts General Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of the study is to evaluate the role of fenestrated/branched stent-grafts in the exclusion of abdominal aortic and thoracoabdominal aneurysms.
Detailed Description
The purpose of the study is to evaluate the role of fenestrated/branched stent-grafts in the exclusion of abdominal aortic and thoracoabdominal aneurysms. The evaluation shall be conducted with subjects that would be expected to have great difficulty tolerating open surgical repair and anatomies not suitable for devices currently marketed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Thoracoabdominal Aneurysm, Abdominal Aortic Aneurysm
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1366 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Endovascular Aneurysm Repair
Arm Type
Experimental
Arm Description
Endovascular Aneurysm Repair of TAAA/AAA with Fenestrated/Branched Stent Grafts
Intervention Type
Device
Intervention Name(s)
Endovascular Aneurysm Repair
Other Intervention Name(s)
Cook Zenith
Intervention Description
Endovascular exclusion of aneurysm
Primary Outcome Measure Information:
Title
Freedom From Aneurysm Rupture
Description
Absence of blood extravasation outside of aneurysm sac demonstrated by CT scan
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
At least 18 years of age.
Not pregnant
Willing and able to comply with two-year follow-up period.
Willing and able to give informed consent prior to enrollment
No known allergy to stainless steel or polyester
No history of anaphylactic reaction to contrast material with an inability to properly prophylax the patient appropriately.
Life expectancy greater than two years
High risk candidate for open surgical repair
Exclusion Criteria:
see above
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Behzad Farivar, M. D.
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32173192
Citation
Zhang J, Brier C, Parodi FE, Kuramochi Y, Lyden SP, Eagleton MJ. Incidence and management of iliac artery aneurysms associated with endovascular treatment of juxtarenal and thoracoabdominal aortic aneurysms. J Vasc Surg. 2020 Oct;72(4):1360-1366. doi: 10.1016/j.jvs.2019.12.040. Epub 2020 Mar 12.
Results Reference
derived
PubMed Identifier
26792544
Citation
Eagleton MJ, Follansbee M, Wolski K, Mastracci T, Kuramochi Y. Fenestrated and branched endovascular aneurysm repair outcomes for type II and III thoracoabdominal aortic aneurysms. J Vasc Surg. 2016 Apr;63(4):930-42. doi: 10.1016/j.jvs.2015.10.095. Epub 2016 Jan 11.
Results Reference
derived
PubMed Identifier
26620715
Citation
Sylvan J, Brier C, Wolski K, Yanof J, Goel V, Kuramochi Y, Eagleton MJ. Impact of alterations in target vessel curvature on branch durability after endovascular repair of thoracoabdominal aortic aneurysms. J Vasc Surg. 2016 Mar;63(3):634-41. doi: 10.1016/j.jvs.2015.09.053. Epub 2015 Nov 29.
Results Reference
derived
PubMed Identifier
25619574
Citation
Mastracci TM, Eagleton MJ, Kuramochi Y, Bathurst S, Wolski K. Twelve-year results of fenestrated endografts for juxtarenal and group IV thoracoabdominal aneurysms. J Vasc Surg. 2015 Feb;61(2):355-64. doi: 10.1016/j.jvs.2014.09.068.
Results Reference
derived
PubMed Identifier
25600335
Citation
O'Callaghan A, Greenberg RK, Eagleton MJ, Bena J, Mastracci TM. Type Ia endoleaks after fenestrated and branched endografts may lead to component instability and increased aortic mortality. J Vasc Surg. 2015 Apr;61(4):908-14. doi: 10.1016/j.jvs.2014.10.085. Epub 2015 Jan 16.
Results Reference
derived
PubMed Identifier
25449006
Citation
O'Callaghan A, Mastracci TM, Eagleton MJ. Staged endovascular repair of thoracoabdominal aortic aneurysms limits incidence and severity of spinal cord ischemia. J Vasc Surg. 2015 Feb;61(2):347-354.e1. doi: 10.1016/j.jvs.2014.09.011. Epub 2014 Oct 23.
Results Reference
derived
PubMed Identifier
24993951
Citation
O'Callaghan A, Mastracci TM, Greenberg RK, Eagleton MJ, Bena J, Kuramochi Y. Outcomes for supra-aortic branch vessel stenting in the treatment of thoracic aortic disease. J Vasc Surg. 2014 Oct;60(4):914-20. doi: 10.1016/j.jvs.2013.12.053. Epub 2014 Jul 1.
Results Reference
derived
PubMed Identifier
24188715
Citation
Eagleton MJ, Shah S, Petkosevek D, Mastracci TM, Greenberg RK. Hypogastric and subclavian artery patency affects onset and recovery of spinal cord ischemia associated with aortic endografting. J Vasc Surg. 2014 Jan;59(1):89-94. doi: 10.1016/j.jvs.2013.07.007. Epub 2013 Nov 1.
Results Reference
derived
PubMed Identifier
23810300
Citation
Mohapatra A, Greenberg RK, Mastracci TM, Eagleton MJ, Thornsberry B. Radiation exposure to operating room personnel and patients during endovascular procedures. J Vasc Surg. 2013 Sep;58(3):702-9. doi: 10.1016/j.jvs.2013.02.032. Epub 2013 Jun 28.
Results Reference
derived
PubMed Identifier
23809203
Citation
Brown CR, Greenberg RK, Wong S, Eagleton M, Mastracci T, Hernandez AV, Rigelsky CM, Moran R. Family history of aortic disease predicts disease patterns and progression and is a significant influence on management strategies for patients and their relatives. J Vasc Surg. 2013 Sep;58(3):573-81. doi: 10.1016/j.jvs.2013.02.239. Epub 2013 Jul 1.
Results Reference
derived
PubMed Identifier
23800455
Citation
Kitagawa A, Greenberg RK, Eagleton MJ, Mastracci TM, Roselli EE. Fenestrated and branched endovascular aortic repair for chronic type B aortic dissection with thoracoabdominal aneurysms. J Vasc Surg. 2013 Sep;58(3):625-34. doi: 10.1016/j.jvs.2013.01.049. Epub 2013 Jun 22.
Results Reference
derived
PubMed Identifier
23611709
Citation
Kitagawa A, Greenberg RK, Eagleton MJ, Mastracci TM. Zenith p-branch standard fenestrated endovascular graft for juxtarenal abdominal aortic aneurysms. J Vasc Surg. 2013 Aug;58(2):291-300. doi: 10.1016/j.jvs.2012.12.087. Epub 2013 Apr 20.
Results Reference
derived
PubMed Identifier
23433817
Citation
Mastracci TM, Greenberg RK, Eagleton MJ, Hernandez AV. Durability of branches in branched and fenestrated endografts. J Vasc Surg. 2013 Apr;57(4):926-33; discussion 933. doi: 10.1016/j.jvs.2012.09.071. Epub 2013 Feb 20.
Results Reference
derived
Learn more about this trial
Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts
We'll reach out to this number within 24 hrs